SCHEMBL1648307

SCHEMBL1648307

CCOC(=O)CC(c1ccc2c(c1)OCCO2)c1c(O)c2ccccc2oc1=O

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.55
CYP2C9 P11712 4/20 0.53
ALB P02768 2/20 0.53
HSD17B10 Q99714 2/20 0.53
ALDH1A1 P00352 2/20 0.53
VKORC1 Q9BQB6 2/20 0.53
KDM4E B2RXH2 1/20 0.53
PCSK7 Q16549 1/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
CYP3A4 P08684 1/20 0.49
TOP2A P11388 1/20 0.49
NQO1 P15559 3/20 0.48
NR1I2 O75469 1/20 0.48
NR3C1 P04150 1/20 0.48
ADRA1A P35348 1/20 0.48
KCNH2 Q12809 1/20 0.48
TOP1 P11387 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1649099 0.87 CYP2C9 (0.57) CYP2C9ALBHSD17B10ALDH1A1VKORC1
SCHEMBL1647638 0.85 CYP2C9 (0.72) ADORA3CYP2C9ALBHSD17B10ALDH1A1
SCHEMBL1647664 0.82 NQO1 (0.65) ADORA3CYP2C9ALBHSD17B10ALDH1A1
SCHEMBL3157772 0.81 CYP2C9 (0.60) ADORA3CYP2C9ALBHSD17B10ALDH1A1
SCHEMBL14078679 0.81 TOP2A (0.62) CYP2C9ALBHSD17B10ALDH1A1VKORC1
SCHEMBL14170275 0.79 NQO1 (0.69) CYP2C9ALDH1A1KDM4EMEN1KMT2A
SCHEMBL5149518 0.78 ADORA3 (0.51) ADORA3CYP2C9ALBHSD17B10ALDH1A1
SCHEMBL1648320 0.77 ADORA3 (0.70) ADORA3CYP2C9ALBHSD17B10ALDH1A1
SCHEMBL5113240 0.77 CYP2C9 (0.69) ADORA3CYP2C9ALBHSD17B10ALDH1A1
SCHEMBL1647648 0.75 ADORA3 (0.67) ADORA3CYP2C9ALBHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161261-B1 Materials and methods for treating coagulation disorders ARMETHEON INC (US) 2013-08-28 EP disclosed
US-7932405-B2 Halogenated ester derivatives of coumarins for the treatment of coagulation disorders ARYX THERAPEUTICS, INC. (US) 2011-04-26 US disclosed
EP-2161261-A1 Materials and methods for treating coagulation disorders Aryx Therapeutics (US) 2010-03-10 EP disclosed
EP-1735296-B1 MATERIALS AND METHODS FOR TREATING COAGULATION DISORDERS ARYX THERAPEUTICS (US) 2009-12-09 EP disclosed